Publication
Article
Health Economic Perspectives in Fibromyalgia: Focus on Pregabalin
This supplement to The American Journal of Managed Care discusses current evidence and strategies to improve clinical and economic outcomes associated with fibromyalgia treatment.
Faculty
Jose Alvir, DrPH
Senior Director
Pfizer, Inc.
New York, NY
Lesley Arnold, MD
Professor of Psychiatry
University of Cincinnati College of Medicine
Cincinnati, OH
Gary Bazalo, MS, MBA
Partner
Managed Solutions, LLC
Conifer, CO
Ariel Berger, MPH
Senior Analyst
Policy Analysis Inc
Brookline, MA
William J. Cardarelli, PharmD
Director of Pharmacy
Harvard Vanguard Medical Associates
Watertown, MA
Arthi Chandran, MPH
Associate Director
Market Access-Global Health Economics and Outcomes Research
Pfizer, Inc.
New York, NY
Daniel Clauw, MD
Professor and Director
Chronic Pain and Fatigue Research Center
Department of Anesthesiology
University of Michigan
Ann Arbor, MI
Michael Deminski, MS, RPh
Senior Director, Medical Affairs
Pfizer, Inc
New York, NY
Ellen M. Dukes, PhD
Senior Director
Pfizer, Inc.
New York, NY
John Edelsberg, MD, MPH
Medical Director
Policy Analysis Inc
Brookline, MA
Mugdha Gore, PhD, BPharm
Principal Consultant
Avalon Health Solutions, Inc.
Philadelphia, PA
John Hanna, MBA
Director, Health Services Research
Humana Inc
Health Services Research Center
Miami, FL
Ashish V. Joshi, PhD
Associate Director
Pfizer, Inc.
New York, NY
Hua Li, MD, PhD
Biostatistician (Scientist)
Humana Inc
Miami, FL
Philip Mease, MD
Seattle Rheumatology Associates
Director, Division of Rheumatology Research
Swedish Medical Center
Clinical Professor
University of Washington School of Medicine
Seattle, WA
Gerry Oster, PhD
Vice President
Policy Analysis Inc
Brookline, MA
Ana Palacio, MD, MPH
Assistant Professor
Department of Medicine
University of Miami
Miami, FL
Alesia Sadosky, PhD, MPH, MBA
Director
Pfizer, Inc.
New York, NY
Robert Sanchez, RPh, MS, PhDc
Director
US Health Economics and Outcomes Research
Pfizer, Inc.
New York, NY
Stuart Silverman, MD
Clinical Professor of Medicine and Rheumatology
UCLA/Cedars-Sinai Medical Center and OMC Clinical Research Center
Los Angeles, CA
Claudia L. Uribe, MD, MHA
Manager, Health Services Research
Humana Inc
Miami, FL
Richard C. Weiss, MS
Partner
Managed Solutions, LLC
Mt. Freedom, NJ
Gergana Zlateva, PhD
Senior Director
Global Market Access Lead
Lyrica Primary Care Business Unit
Pfizer, Inc.
New York, NY
Faculty Disclosures
These participants report relationships with the following organizations:
Jose Alvir, DrPH
Employee/stockholder: Pfizer, Inc.
Lesley Arnold, MD
Consultant:
Allergan, AstraZeneca, Boehringer Ingelheim, Cypress Bioscience, Forest, Lilly, Pfizer, Inc., sanofi-aventis, Takeda, Theravance, UCB, Wyeth Pharmaceuticals
Grant/research support:
Allergan, Boehringer Ingelheim, Cypress Bioscience, Forest, Lilly, Pfizer, Inc., Wyeth Pharmaceuticals
Speakers' bureau:
Forest
Gary Bazalo, MS, MBA
Receipt of payment for the conduct of the study and article development
Ariel Berger, MPH
Employee of Policy Analysis Inc, which received financial support from Pfizer, Inc. for the conduct of this analysis and article development
Arthi Chandran, MPH
Employee/stockholder:
Pfizer, Inc.
Daniel Clauw, MD
Consultant:
AstraZeneca, Cypress Bioscience, Forest, Lilly, Pfizer, Inc., Pierre Fabre, UCB
Grant/research support:
Forest, Pfizer, Inc.
Michael Deminski, MS, RPh
Employee/stockholder: Pfizer, Inc.
Ellen M. Dukes, PhD
Employee/stockholder: Pfizer, Inc.
John Edelsberg, MD, MPH
Employee of Policy Analysis Inc, which received financial support from Pfizer, Inc. for the conduct of this analysis and article development
Mugdha Gore, PhD, BPharm
Employee of Policy Analysis Inc, which received financial support from Pfizer, Inc. for the conduct of this analysis and article development
Stockholder:
Pfizer, Inc.
John Hanna, MBA
Consultant to Pfizer, Inc. during the conduct of this study and article development
Ashish V. Joshi, PhD
Employee/stockholder: Pfizer, Inc.
Hua Li, MD, PhD
Consultant to Pfizer, Inc. during the conduct of this study and article development
Philip Mease, MD
Consultant/grant recipient:
Allergan, Boehringer Ingelheim, Cypress Bioscience, Forest, Fralex, Lilly, Pfizer, Inc.
Honoraria/speakers' bureau:
Cypress Bioscience, Forest, Lilly, Pfizer, Inc.
Gerry Oster, PhD
Employee of Policy Analysis Inc, which received financial support from Pfizer, Inc. for the conduct of this analysis and article development
Ana Palacio, MD, MPH
Consultant to Pfizer, Inc. during the conduct of this study and article development
Alesia Sadosky, PhD, MPH, MBA
Employee/stockholder: Pfizer, Inc.
Robert Sanchez, RPh, MS
Employee/stockholder: Pfizer, Inc.
Stuart Silverman, MD
Consultant/advisory board member:
Lilly, Pfizer, Inc.
Grants:
Lilly, Pfizer, Inc.
Lecture fees:
Lilly, Pfizer, Inc.
Claudia L. Uribe, MD, MHA
Consultant to Pfizer, Inc. during the conduct of this study and article development
Richard C. Weiss, MS
Receipt of payment for the conduct of the study and article development
Gergana Zlateva, PhD
Employee/stockholder: Pfizer, Inc.
William J. Cardarelli, PharmD, has nothing to disclose relative to the topic of this supplement.
This supplement was funded by Pfizer, Inc.
The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.